IOVANCE BIOTHERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Iovance Biotherapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Iovance Biotherapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 305M shares, a 19.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 305M +48.9M +19.1% Nov 1, 2024 10-Q 2024-11-07
Q2 2024 304M +55.7M +22.5% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 280M +55.4M +24.7% May 2, 2024 10-Q 2024-05-09
Q3 2023 256M +98.1M +62.1% Oct 30, 2023 10-Q 2023-11-07
Q2 2023 248M +90M +57% Aug 3, 2023 10-Q 2023-08-08
Q1 2023 224M +67.3M +42.8% May 2, 2023 10-Q 2023-05-10
Q3 2022 158M +941K +0.6% Oct 26, 2022 10-Q 2022-11-03
Q2 2022 158M +158M Jul 25, 2022 10-Q 2022-08-04
Q1 2022 157M +4.32M +2.83% Apr 25, 2022 10-Q 2022-05-05
Q3 2021 157M +10.2M +6.96% Oct 26, 2021 10-Q 2021-11-04
Q2 2021 15* -146M Jul 28, 2021 10-Q 2021-08-05
Q1 2021 153M +26M +20.5% Apr 26, 2021 10-Q 2021-05-06
Q3 2020 147M +20.5M +16.2% Oct 26, 2020 10-Q 2020-11-05
Q2 2020 146M +22.6M +18.3% Jul 28, 2020 10-Q 2020-08-06
Q1 2020 127M +3.35M +2.71% Apr 28, 2020 10-Q 2020-05-05
Q3 2019 126M +3.03M +2.46% Oct 31, 2019 10-Q 2019-11-04
Q2 2019 124M +28.2M +29.5% Jul 25, 2019 10-Q 2019-08-01
Q1 2019 124M +33.9M +37.8% Apr 30, 2019 10-Q 2019-05-07
Q4 2018 123M Feb 13, 2019 10-K 2019-02-28
Q3 2018 123M +50.5M +69.6% Oct 31, 2018 10-Q 2018-11-06
Q2 2018 95.6M +32.9M +52.5% Jul 31, 2018 10-Q 2018-08-07
Q1 2018 89.6M +27.3M +43.9% Apr 30, 2018 10-Q 2018-05-10
Q3 2017 72.6M +10.5M +17% Oct 31, 2017 10-Q 2017-11-02
Q2 2017 62.7M +4.25M +7.27% Aug 1, 2017 10-Q 2017-08-03
Q1 2017 62.3M +13.8M +28.3% Mar 2, 2017 10-K 2017-03-09
Q3 2016 62.1M +14.3M +29.8% Nov 1, 2016 10-Q 2016-11-04
Q2 2016 58.4M +11.2M +23.8% Jul 28, 2016 10-Q 2016-08-09
Q1 2016 48.6M +4.47M +10.1% Apr 30, 2016 10-Q 2016-05-09
Q3 2015 47.8M +20.2M +73.1% Oct 31, 2015 10-Q 2015-11-06
Q2 2015 47.2M +20M +73.3% Aug 7, 2015 10-Q 2015-08-10
Q1 2015 44.1M +22M +99.8% Mar 16, 2015 10-K 2015-03-16
Q3 2014 27.6M -1.48B -98.2% Nov 7, 2014 10-Q 2014-11-13
Q2 2014 27.2M Aug 14, 2014 10-Q 2014-08-08
Q1 2014 22.1M Mar 31, 2014 10-K 2014-03-28
Q3 2013 1.51B Sep 13, 2013 10-K 2013-09-23
Q4 2012 78.3M +4.65M +6.32% Jan 18, 2013 10-Q 2013-01-25
Q2 2012 78.3M Aug 14, 2012 10-Q/A 2012-09-10
Q1 2012 79M Mar 28, 2012 10-K 2012-03-30
Q4 2011 73.6M Nov 18, 2011 10-Q 2011-11-21
Q3 2011 77.7M Aug 15, 2011 10-Q/A 2011-09-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.